West he ste treatment effect is ideal as a new type of type 2 diabetes mellitus anti-diabetic drugs, west his dean has the dependence, blood sugar ste hypoglycemic effect, moderate increase in in'sulin secretion is not going to happen at the same time low blood sugar, effectively reduce the advantages of the hunger, and no nausea and vomiting Edema and increase the body quality of side effects
Clinical studies have shown that sitatliptin ste as monotherapy in patients with type 2 diabetes can significantly reduce glycosylated hemoglobin (HbA1c) levels When used in combination with metformin or TZDs, it has a significant adjunctive effect, targeting the three main defects of type 2 diabetes: in'sulin resistance,β -dysfunction (reduced in'sulin release), and α -dysfunction (failure to inhibit hepatic glucose production) However, this drug should not be used for the treatment of type 1 diabetes or diabetic ketoacidosis
